Irreversible trapping of the DNA-topoisomerase I covalent complex: Affinity labeling of the camptothecin binding site

Robert P. Hertzberg, Robert W. Busby, Mary Jo Caranfa, Kenneth G. Holden, Randall K. Johnson, Sidney Hecht, William D. Kingsbury

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Camptothecin (CPT) binds reversibly to, and thereby stabilizes, the cleavable complex formed between DNA and topoisomerase I. The nature of the interaction of CPT with the DNA-topoisomerase I binary complex was studied by the use of two affinity labeling reagents structurally related to camptothecin: 10-bromoacetamidomethylcamptothecin (BrCPT) and 7-methyl-10-bromoacetamidomethylcamptothecin (BrCPTMe). These compounds have been shown to trap the DNA-topoisomerase I complex irreversibly. Although cleavage of DNA plasmid mediated by topoisomerase I and camptothecin was reduced significantly by treatment with high salt or excess competitor DNA, enzymemediated DNA cleavage stabilized by BrCTPMe persisted for at least 4 h after similar treatment. The production of irreversible topoisomerase I-DNA cleavage was time-dependent, suggesting that BrCPTMe first bound noncovalently to the enzyme-DNA complex and, in a second slower step, alkylated the enzyme or DNA in a manner that prevented DNA ligation. The formation of a covalent linkage was supported by experiments that employed [3H]BrCPT, which was shown to label topoisomerase I within the enzyme-DNA complex. [3H]BrCPT labeling of topoisomerase I was enhanced greatly by the presence of DNA; very little labeling of isolated topoisomerase I or isolated DNA occurred. Even in the presence of DNA, [3H]BrCPT labeling of topoisomerase I was inhibited by camptothecin, suggesting that both CPT and BrCPT bound to the same site on the DNA-topoisomerase I binary complex. These studies provide further evidence that a binding site for camptothecin is created as the DNA-topoisomerase I complex is formed and suggest that the A-ring of camptothecin is proximate to an enzyme residue.

Original languageEnglish (US)
Pages (from-to)19287-19295
Number of pages9
JournalJournal of Biological Chemistry
Volume265
Issue number31
StatePublished - Nov 5 1990
Externally publishedYes

Fingerprint

Camptothecin
Type I DNA Topoisomerase
Labeling
Binding Sites
DNA
DNA Cleavage
Enzymes
Affinity Labels
Ligation
Labels
Plasmids
Salts

ASJC Scopus subject areas

  • Biochemistry

Cite this

Hertzberg, R. P., Busby, R. W., Caranfa, M. J., Holden, K. G., Johnson, R. K., Hecht, S., & Kingsbury, W. D. (1990). Irreversible trapping of the DNA-topoisomerase I covalent complex: Affinity labeling of the camptothecin binding site. Journal of Biological Chemistry, 265(31), 19287-19295.

Irreversible trapping of the DNA-topoisomerase I covalent complex : Affinity labeling of the camptothecin binding site. / Hertzberg, Robert P.; Busby, Robert W.; Caranfa, Mary Jo; Holden, Kenneth G.; Johnson, Randall K.; Hecht, Sidney; Kingsbury, William D.

In: Journal of Biological Chemistry, Vol. 265, No. 31, 05.11.1990, p. 19287-19295.

Research output: Contribution to journalArticle

Hertzberg, RP, Busby, RW, Caranfa, MJ, Holden, KG, Johnson, RK, Hecht, S & Kingsbury, WD 1990, 'Irreversible trapping of the DNA-topoisomerase I covalent complex: Affinity labeling of the camptothecin binding site', Journal of Biological Chemistry, vol. 265, no. 31, pp. 19287-19295.
Hertzberg, Robert P. ; Busby, Robert W. ; Caranfa, Mary Jo ; Holden, Kenneth G. ; Johnson, Randall K. ; Hecht, Sidney ; Kingsbury, William D. / Irreversible trapping of the DNA-topoisomerase I covalent complex : Affinity labeling of the camptothecin binding site. In: Journal of Biological Chemistry. 1990 ; Vol. 265, No. 31. pp. 19287-19295.
@article{c05544e36e1f4e5e8169320800b50769,
title = "Irreversible trapping of the DNA-topoisomerase I covalent complex: Affinity labeling of the camptothecin binding site",
abstract = "Camptothecin (CPT) binds reversibly to, and thereby stabilizes, the cleavable complex formed between DNA and topoisomerase I. The nature of the interaction of CPT with the DNA-topoisomerase I binary complex was studied by the use of two affinity labeling reagents structurally related to camptothecin: 10-bromoacetamidomethylcamptothecin (BrCPT) and 7-methyl-10-bromoacetamidomethylcamptothecin (BrCPTMe). These compounds have been shown to trap the DNA-topoisomerase I complex irreversibly. Although cleavage of DNA plasmid mediated by topoisomerase I and camptothecin was reduced significantly by treatment with high salt or excess competitor DNA, enzymemediated DNA cleavage stabilized by BrCTPMe persisted for at least 4 h after similar treatment. The production of irreversible topoisomerase I-DNA cleavage was time-dependent, suggesting that BrCPTMe first bound noncovalently to the enzyme-DNA complex and, in a second slower step, alkylated the enzyme or DNA in a manner that prevented DNA ligation. The formation of a covalent linkage was supported by experiments that employed [3H]BrCPT, which was shown to label topoisomerase I within the enzyme-DNA complex. [3H]BrCPT labeling of topoisomerase I was enhanced greatly by the presence of DNA; very little labeling of isolated topoisomerase I or isolated DNA occurred. Even in the presence of DNA, [3H]BrCPT labeling of topoisomerase I was inhibited by camptothecin, suggesting that both CPT and BrCPT bound to the same site on the DNA-topoisomerase I binary complex. These studies provide further evidence that a binding site for camptothecin is created as the DNA-topoisomerase I complex is formed and suggest that the A-ring of camptothecin is proximate to an enzyme residue.",
author = "Hertzberg, {Robert P.} and Busby, {Robert W.} and Caranfa, {Mary Jo} and Holden, {Kenneth G.} and Johnson, {Randall K.} and Sidney Hecht and Kingsbury, {William D.}",
year = "1990",
month = "11",
day = "5",
language = "English (US)",
volume = "265",
pages = "19287--19295",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - Irreversible trapping of the DNA-topoisomerase I covalent complex

T2 - Affinity labeling of the camptothecin binding site

AU - Hertzberg, Robert P.

AU - Busby, Robert W.

AU - Caranfa, Mary Jo

AU - Holden, Kenneth G.

AU - Johnson, Randall K.

AU - Hecht, Sidney

AU - Kingsbury, William D.

PY - 1990/11/5

Y1 - 1990/11/5

N2 - Camptothecin (CPT) binds reversibly to, and thereby stabilizes, the cleavable complex formed between DNA and topoisomerase I. The nature of the interaction of CPT with the DNA-topoisomerase I binary complex was studied by the use of two affinity labeling reagents structurally related to camptothecin: 10-bromoacetamidomethylcamptothecin (BrCPT) and 7-methyl-10-bromoacetamidomethylcamptothecin (BrCPTMe). These compounds have been shown to trap the DNA-topoisomerase I complex irreversibly. Although cleavage of DNA plasmid mediated by topoisomerase I and camptothecin was reduced significantly by treatment with high salt or excess competitor DNA, enzymemediated DNA cleavage stabilized by BrCTPMe persisted for at least 4 h after similar treatment. The production of irreversible topoisomerase I-DNA cleavage was time-dependent, suggesting that BrCPTMe first bound noncovalently to the enzyme-DNA complex and, in a second slower step, alkylated the enzyme or DNA in a manner that prevented DNA ligation. The formation of a covalent linkage was supported by experiments that employed [3H]BrCPT, which was shown to label topoisomerase I within the enzyme-DNA complex. [3H]BrCPT labeling of topoisomerase I was enhanced greatly by the presence of DNA; very little labeling of isolated topoisomerase I or isolated DNA occurred. Even in the presence of DNA, [3H]BrCPT labeling of topoisomerase I was inhibited by camptothecin, suggesting that both CPT and BrCPT bound to the same site on the DNA-topoisomerase I binary complex. These studies provide further evidence that a binding site for camptothecin is created as the DNA-topoisomerase I complex is formed and suggest that the A-ring of camptothecin is proximate to an enzyme residue.

AB - Camptothecin (CPT) binds reversibly to, and thereby stabilizes, the cleavable complex formed between DNA and topoisomerase I. The nature of the interaction of CPT with the DNA-topoisomerase I binary complex was studied by the use of two affinity labeling reagents structurally related to camptothecin: 10-bromoacetamidomethylcamptothecin (BrCPT) and 7-methyl-10-bromoacetamidomethylcamptothecin (BrCPTMe). These compounds have been shown to trap the DNA-topoisomerase I complex irreversibly. Although cleavage of DNA plasmid mediated by topoisomerase I and camptothecin was reduced significantly by treatment with high salt or excess competitor DNA, enzymemediated DNA cleavage stabilized by BrCTPMe persisted for at least 4 h after similar treatment. The production of irreversible topoisomerase I-DNA cleavage was time-dependent, suggesting that BrCPTMe first bound noncovalently to the enzyme-DNA complex and, in a second slower step, alkylated the enzyme or DNA in a manner that prevented DNA ligation. The formation of a covalent linkage was supported by experiments that employed [3H]BrCPT, which was shown to label topoisomerase I within the enzyme-DNA complex. [3H]BrCPT labeling of topoisomerase I was enhanced greatly by the presence of DNA; very little labeling of isolated topoisomerase I or isolated DNA occurred. Even in the presence of DNA, [3H]BrCPT labeling of topoisomerase I was inhibited by camptothecin, suggesting that both CPT and BrCPT bound to the same site on the DNA-topoisomerase I binary complex. These studies provide further evidence that a binding site for camptothecin is created as the DNA-topoisomerase I complex is formed and suggest that the A-ring of camptothecin is proximate to an enzyme residue.

UR - http://www.scopus.com/inward/record.url?scp=0025037336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025037336&partnerID=8YFLogxK

M3 - Article

C2 - 2172250

AN - SCOPUS:0025037336

VL - 265

SP - 19287

EP - 19295

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -